Cargando…
A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539526/ https://www.ncbi.nlm.nih.gov/pubmed/35460156 http://dx.doi.org/10.1111/dth.15533 |
| _version_ | 1784803507376750592 |
|---|---|
| author | Bernardini, Nicoletta Skroza, Nevena Marraffa, Federica Prevete, Elisabeth Mambrin, Alessandra Proietti, Ilaria Tolino, Ersilia Caviglia, Martina Di Guardo, Antonio Rossi, Giovanni Volpe, Salvatore Bersani, Giuseppe Potenza, Concetta |
| author_facet | Bernardini, Nicoletta Skroza, Nevena Marraffa, Federica Prevete, Elisabeth Mambrin, Alessandra Proietti, Ilaria Tolino, Ersilia Caviglia, Martina Di Guardo, Antonio Rossi, Giovanni Volpe, Salvatore Bersani, Giuseppe Potenza, Concetta |
| author_sort | Bernardini, Nicoletta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9539526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95395262022-10-14 A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab Bernardini, Nicoletta Skroza, Nevena Marraffa, Federica Prevete, Elisabeth Mambrin, Alessandra Proietti, Ilaria Tolino, Ersilia Caviglia, Martina Di Guardo, Antonio Rossi, Giovanni Volpe, Salvatore Bersani, Giuseppe Potenza, Concetta Dermatol Ther Letters John Wiley & Sons, Inc. 2022-05-04 2022-07 /pmc/articles/PMC9539526/ /pubmed/35460156 http://dx.doi.org/10.1111/dth.15533 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters Bernardini, Nicoletta Skroza, Nevena Marraffa, Federica Prevete, Elisabeth Mambrin, Alessandra Proietti, Ilaria Tolino, Ersilia Caviglia, Martina Di Guardo, Antonio Rossi, Giovanni Volpe, Salvatore Bersani, Giuseppe Potenza, Concetta A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title | A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title_full | A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title_fullStr | A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title_full_unstemmed | A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title_short | A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab |
| title_sort | case of twins affected by psoriasis, psoriatic arthritis and autism: five years of efficacious and safe treatment with secukinumab |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539526/ https://www.ncbi.nlm.nih.gov/pubmed/35460156 http://dx.doi.org/10.1111/dth.15533 |
| work_keys_str_mv | AT bernardininicoletta acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT skrozanevena acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT marraffafederica acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT preveteelisabeth acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT mambrinalessandra acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT proiettiilaria acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT tolinoersilia acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT cavigliamartina acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT diguardoantonio acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT rossigiovanni acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT volpesalvatore acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT bersanigiuseppe acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT potenzaconcetta acaseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT bernardininicoletta caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT skrozanevena caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT marraffafederica caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT preveteelisabeth caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT mambrinalessandra caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT proiettiilaria caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT tolinoersilia caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT cavigliamartina caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT diguardoantonio caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT rossigiovanni caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT volpesalvatore caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT bersanigiuseppe caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab AT potenzaconcetta caseoftwinsaffectedbypsoriasispsoriaticarthritisandautismfiveyearsofefficaciousandsafetreatmentwithsecukinumab |